Clinical Research Support Unit

THE TISCH CANCER INSTITUTE

CONNECT WITH US

The Clinical Research Support Unit provides infrastructure for the development, conduct, and reporting of innovative clinical research across the Mount Sinai Health System. The Unit’s clinical research professionals are dedicated exclusively to cancer-related trials and support faculty engaged in clinical research across disease areas, ensuring high-quality clinical investigation through our robust regulatory and quality assurance programs.

The Unit is organized into specialized units known as disease management teams, each led by a physician investigator and comprised of dedicated managers, clinical research nurses, research coordinators, data coordinators, and regulatory coordinators. More than one-third of our research professionals are certified in their area of expertise.

Types of trials we support:

Investigator-initiated trials
Multicenter cooperative group/National Clinical Trial Network
Industry-sponsored trials
Research consortium

Research Consortia

The Clinical Research Support Unit currently supports two research consortia:

MAGIC-Mount Sinai Acute Graft-Versus-Host-Disease International Consortium: A consortium of 25 stem cell transplant centers in the United States, Canada, Europe, and Asia that collaborate on clinical trials to prevent and treat acute graft-versus-host-disease. For more information, contact Rachel Young .
The Myeloproliferative Neoplasms Research Consortium: An interactive collaboration among laboratory scientists, clinical scientists, and a biostatistics team. The consortium develops and evaluates treatments to improve the survival of patients with myeloproliferative neoplasms. It has investigators across 11 institutions in the United States and Canada. For more information, contact Ashley Yu.

The Unit supports all cancer clinical trials according to guidelines in The Tisch Cancer Institute’s Data and Safety Monitoring Plan. The goal is to ensure that all clinical trials implemented at our institution are high quality and are routinely monitored, and that our reporting techniques fulfill sponsor, institutional, and governmental requirements.

To promote academic excellence and equitable care for all, The Tisch Cancer Institute fosters a supportive environment that allows all members of our community to thrive and contribute toward ensuring that clinical trial enrollment includes broad population representation in order to secure results that are widely applicable. Clinical trials at The Tisch Cancer Institute include significant percentages of patients representing minority populations and women, as well as pediatric and elderly patients.

Careers

The field of clinical research provides opportunities to make meaningful contributions to science that powerfully affect the lives of cancer patients. At The Tisch Cancer Institute, we are dedicated to developing a sustainable cancer-focused clinical trial workforce, and we regularly seek promising individuals to join our talented team. We also educate the next generation of clinical research professionals through our Master of Science in Clinical Research and our Clinical Research Training Program Certificate.